Cancer immunotherapy significantly improves the immune‐deserted tumor microenvironment and has achieved tremendous success.[1] The eradication of cancer cells by the immune system primarily occurs through T cell‐mediated recognition and killing of tumors.[2, 3] T cells recognize tumor antigens bounded with MHC molecules expressed on tumor cells for immune recognition. The gene discussed is HLA-C; the disease is cancer.